Natco Pharma stock reports INR 1,279.35 crore rights issue plan

Published on 09/26/2026 at 11:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Natco Pharma stock traded at INR 839.30 on September 25, 2026, down 0.32 percent from INR 842.00. Q1 FY27 revenue was INR 794.40 crore, while PAT reached INR 206.50 crore.

Natco, INE987B01026, Illustration mit AI erstellt.

Natco Pharma (ISIN INE987B01026) stock was INR 839.30 on the NSE on September 25, 2026, down 0.32 percent from the previous close of INR 842.00. The board approved an INR 1,279.35 crore rights issue, according to HDFC Sky on September 25, 2026.

Rights issue sets October dates

HDFC Sky reported that Natco Pharma will issue 17,058,082 shares at INR 750 per share. The entitlement ratio is 2 rights shares for every 21 shares held, with October 1, 2026 set as the record date.

The subscription period is scheduled for October 12 through October 22, 2026, while on-market renunciation is scheduled for October 12 through October 16, 2026. At full subscription, the outstanding share count would rise from 179,109,870 to 196,167,952.

Quarterly revenue falls 42.87 percent

Natco Pharma's latest reported quarter was June 2026. The Economic Times lists total income of INR 794.40 crore, down from INR 1,390.60 crore in June 2025, a 42.87 percent decline. Profit after tax was INR 206.50 crore, compared with INR 480.70 crore a year earlier, while the net profit margin was 25.99 percent.

The rights issue therefore arrives alongside a sharp year-over-year revenue comparison. The issue price of INR 750 is INR 89.30 below the September 25 stock price, creating a clearly defined reference point for eligible shareholders.

Stock stays below yearly high

Natco Pharma's 52-week range was INR 789.00 to INR 1,226.80 as of September 25, 2026. The stock stood 31.59 percent below its yearly high and INR 50.30 above its yearly low.

Market capitalization was INR 150.3269 billion, and NSE volume reached 369,863 shares on September 25, 2026. The session high was INR 850.10 and the session low was INR 834.25, placing the reference price inside that daily range.

Stock price and investor reference

Natco Pharma stock was INR 839.30 on the NSE on September 25, 2026, with a daily change of minus 0.32 percent. The rights issue schedule, INR 750 subscription price and 2-for-21 entitlement ratio are the central near-term reference points for the equity.